Selective internal radiation therapy (SIRT) with yttrium-90 microspheres and peri-procedural FOLFIRI/irinotecan in pre-treated colorectal liver metastases patients: an analysis of outcomes from a UK cancer centre between 2009 and 2017.
dc.contributor.author | Wilson, Gregory | |
dc.contributor.author | Bentley, D | |
dc.contributor.author | Mullamitha, Saifee A | |
dc.contributor.author | Braun, Michael S | |
dc.contributor.author | Nasralla, Magdy | |
dc.contributor.author | Bell, Jon | |
dc.contributor.author | Mullan, David | |
dc.contributor.author | Hasan, Jurjees | |
dc.contributor.author | Saunders, Mark P | |
dc.contributor.author | Marti-Marti, Francisca | |
dc.contributor.author | McBain, Catherine A | |
dc.contributor.author | Alam, Nooreen | |
dc.contributor.author | Laasch, Hans-Ulrich | |
dc.contributor.author | Najran, Pavan | |
dc.contributor.author | Westwood, Thomas D | |
dc.contributor.author | Jeans, Steve | |
dc.contributor.author | Tipping, Jill | |
dc.contributor.author | Manoharan, Prakash | |
dc.contributor.author | Lawrance, Jeremy A L | |
dc.date.accessioned | 2018-10-15T16:50:53Z | |
dc.date.available | 2018-10-15T16:50:53Z | |
dc.date.issued | 2018-06 | |
dc.identifier.citation | Selective internal radiation therapy (SIRT) with yttrium-90 microspheres and peri-procedural FOLFIRI/irinotecan in pre-treated colorectal liver metastases patients: an analysis of outcomes from a UK cancer centre between 2009 and 2017 2018, 29(Suppl_5): Ann Oncol | en |
dc.identifier.issn | 0923-7534 | |
dc.identifier.issn | 1569-8041 | |
dc.identifier.doi | 10.1093/annonc/mdy151.274 | |
dc.identifier.uri | http://hdl.handle.net/10541/621271 | |
dc.language.iso | en | en |
dc.relation.url | https://academic.oup.com/annonc/article/doi/10.1093/annonc/mdy151.274/5039520 | en |
dc.rights | Archived with thanks to Annals of Oncology | en |
dc.title | Selective internal radiation therapy (SIRT) with yttrium-90 microspheres and peri-procedural FOLFIRI/irinotecan in pre-treated colorectal liver metastases patients: an analysis of outcomes from a UK cancer centre between 2009 and 2017. | en |
dc.type | Meetings and Proceedings | en |
dc.contributor.department | The Christie NHS Foundation Trust, Manchester, UK | en |
dc.identifier.journal | Annals of Oncology | en |
dc.contributor.institution | The Christie NHS Foundation Trust, Manchester, UK | |
dc.contributor.institution | The Christie NHS Foundation Trust, Manchester, UK | |
dc.contributor.institution | The Christie Hospital NHS Foundation Trust, Manchester, UK | |
dc.contributor.institution | The Christie NHS Foundation Trust, Manchester, UK | |
dc.contributor.institution | The Christie NHS Foundation Trust, Manchester, UK | |
dc.contributor.institution | The Christie NHS Foundation Trust, Manchester, UK | |
dc.contributor.institution | The Christie Hospital, Manchester, UK | |
dc.contributor.institution | The Christie NHS Foundation Trust, Manchester, UK | |
dc.contributor.institution | Christie Hospital NHS Foundation Trust, Manchester, UK | |
dc.contributor.institution | The Christie NHS Foundation Trust, Manchester, UK | |
dc.contributor.institution | The Christie NHS Foundation Trust, Manchester, UK | |
dc.contributor.institution | The Christie NHS Foundation Trust, Manchester, UK | |
dc.contributor.institution | The Christie Hospital, Manchester, UK | |
dc.contributor.institution | The Christie NHS Foundation Trust, Manchester, UK | |
dc.contributor.institution | The Christie NHS Foundation Trust, Manchester, UK | |
dc.contributor.institution | The Christie NHS Foundation Trust, Manchester, UK | |
dc.contributor.institution | The Christie NHS Foundation Trust, Manchester, UK | |
dc.contributor.institution | The Christie NHS Foundation Trust, Manchester, UK | |
dc.contributor.institution | The Christie NHS Foundation Trust, Manchester, UK |